News
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock of late, since mid-February, as the San Francisco, CA-based health and wellness platform’s
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Ecolab Inc. ECL has been gaining from its solid product portfolio. The optimism, led by a solid first-quarter 2025 performance and continued focus on research and development, is expected to
IHS Q1 Earnings Coming Up: Buy Now or Wait for the Results?
IHS Holding Limited IHS is scheduled to release first-quarter 2025 results on May 20, before market open. The Zacks Consensus Estimate for earnings is currently pegged at 17 cents per share on
ETFs in Focus Post Walmart Q1 Earnings
Walmart WMT reported better-than-expected first-quarter fiscal 2026 results. The mega-retailer maintained its full-year outlook but warned of tariff-related price hikes later this month. WMT shares
Canadian Solar Q1 Loss Lower Than Expected, Revenues Fall Y/Y
Canadian Solar, Inc. CSIQ reported a first-quarter 2025 loss of $1.07 per share, narrower than the Zacks Consensus Estimate of a loss of $1.50 per share. The figure, however, deteriorated from the
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
GE HealthCare Technologies Inc. GEHC recently announced the launch of CleaRecon DL, an innovative AI-based deep learning technology designed to enhance 3D cone-beam computed tomography (CBCT)
Boeing Secures a Contract for 210 Widebody Aircraft From Qatar Airways
The Boeing Company BA recently clinched a contract for delivering 210 of its widebody aircraft from Qatar Airways. Per the terms of the contract, Boeing will deliver 130 787 Dreamliners and 30
Applied Materials Q2 Earnings Beat Estimates, Revenues Rise Y/Y
Applied Materials Inc. AMAT reported second-quarter fiscal 2025 non-GAAP earnings of $2.39 per share, which beat the Zacks Consensus Estimate by 3.5%. This company reported earnings of $2.09 per
Should Investors Buy, Sell or Hold PANW Stock Before Q3 Earnings?
Palo Alto Networks, Inc. PANW is scheduled to report its third-quarter fiscal 2025 results on May 20.
Palo Alto Networks projects its fiscal third-quarter revenues in the range of $2.26-$2.29
Wall Street Analysts Believe SkyWater Technology (SKYT) Could Rally 34.97%: Here's is How to Trade
SkyWater Technology, Inc. (SKYT) closed the last trading session at $8.15, gaining 23.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Stoke Therapeutics (STOK) Could Surge 132.4%: Read This Before Placing a Bet
Stoke Therapeutics, Inc. (STOK) closed the last trading session at $9.63, gaining 25.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
Immunocore Holdings PLC Sponsored ADR (IMCR) closed the last trading session at $29.06, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term
Wall Street Analysts Think Backblaze (BLZE) Could Surge 103.57%: Read This Before Placing a Bet
Shares of Backblaze, Inc. (BLZE) have gained 13.4% over the past four weeks to close the last trading session at $5.32, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Think Zoetis (ZTS) Could Surge 26.18%: Read This Before Placing a Bet
Zoetis (ZTS) closed the last trading session at $160.35, gaining 7.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade
Kamada (KMDA) closed the last trading session at $6.86, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade
Seres Therapeutics (MCRB) closed the last trading session at $7.41, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Predict a 310.96% Upside in Candel Therapeutics (CADL): Here's What You Should Know
Candel Therapeutics, Inc. (CADL) closed the last trading session at $5.11, gaining 11.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Believe Aris Mining Corporation (ARMN) Could Rally 44.68%: Here's is How to Trade
Aris Mining Corporation (ARMN) closed the last trading session at $5.73, gaining 5.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
How Much Upside is Left in Vertical Aerospace (EVTL)? Wall Street Analysts Think 81.02%
Shares of Vertical Aerospace Ltd. (EVTL) have gained 64.9% over the past four weeks to close the last trading session at $5.69, but there could still be a solid upside left in the stock if
Compass Minerals (CMP) Now Trades Above Golden Cross: Time to Buy?
Compass Minerals International, Inc. (CMP) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CMP's 50-day simple moving average
Should You Buy Northrim BanCorp (NRIM) After Golden Cross?
Northrim BanCorp Inc (NRIM) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NRIM's 50-day simple moving average broke out above
Calix (CALX) Just Flashed Golden Cross Signal: Do You Buy?
Calix, Inc (CALX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, CALX's 50-day simple moving average crossed above its
Home Bancorp (HBCP) Now Trades Above Golden Cross: Time to Buy?
Home Bancorp, Inc. (HBCP) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HBCP's 50-day simple moving average broke out above its
Here's Why CVS Health (CVS) Looks Ripe for Bottom Fishing
Shares of CVS Health (CVS) have been struggling lately and have lost 10.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
A downtrend has been apparent in Calidi Biotherapeutics, Inc. (CLDI) lately. While the stock has lost 14% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was


